Showing results (31-40 of 248) with videos related to
Sort By:
Pageof 25
Immunology and Cell Biology|September 13, 2003
Is macrophage migration inhibitory factor a therapeutic target in systemic lupus erythematosus?Alberta Y Hoi, Eric F Morand, Michelle LeechImmunology and Cell Biology|June 2, 2022
Investigating immunoregulatory effects of myeloid cell autophagy in acute and chronic inflammationMd Abul Hasnat, IanIan Cheang, Wendy Dankers, et al.Nature Reviews. Rheumatology|July 23, 2014
The need to define treatment goals for systemic lupus erythematosusKate Franklyn, Alberta Hoi, Mandana Nikpour, et al.Inflammation & Allergy Drug Targets|September 28, 2007
Macrophage migration inhibitory factor: a therapeutic target across inflammatory diseasesAlberta Y Hoi, Magdy N Iskander, Eric F MorandLupus Science & Medicine|May 21, 2026
Can disease activity and treatment responses be captured by a core set of domains in SLE clinical trials? An analysis of phase III belimumab trial dataAngela Lin, Rangi Kandane-Rathnayake, Eric F Morand, et al.Infection, Disease & Health|December 7, 2020
Breaking the chain of transmission within a tertiary health service: An approach to contact tracing during the COVID-19 pandemicRhonda L Stuart, Wendy Zhu, Eric F Morand, et al.Mediators of Inflammation|August 3, 2006
Regulation of annexin I in rheumatoid synovial cells by glucocorticoids and interleukin-1Eric F Morand, Pam Hall, Paul Hutchinson, et al.Nature Reviews. Rheumatology|March 12, 2014
The BAFF/APRIL system in SLE pathogenesisFabien B Vincent, Eric F Morand, Pascal Schneider, et al.The Lancet. Rheumatology|January 30, 2024
Clinician-reported outcome measures in lupus trials: a problem worth solvingKathryn Connelly, Vera Golder, Rangi Kandane-Rathnayake, et al.Immunology and Cell Biology|July 13, 2020
Necrotic cell death increases the release of macrophage migration inhibitory factor by monocytes/macrophagesWendy Dankers, Md Abul Hasnat, Vanesa Swann, et al.Pageof 25